Browse by Sector

Explore NYSE stocks by their primary economic sector.

All NYSE Stocks Financials 919 Industrials 378 Consumer Discretionary 252 Real Estate 216 Energy 214 Materials 203 Healthcare 160 Information Technology 152 Utilities 111 Consumer Staples 95 Communication Services 89

Industries in Healthcare

Refine the list using the company’s more specific operating industry.

Healthcare Equipment & Supplies 42 Healthcare Providers & Services 39 Biotechnology 30 Pharmaceuticals 27 Life Sciences Tools & Services 15 Health Care Technology 7
Industry stocks

Biotechnology Stocks on NYSE

Compare NYSE-listed Biotechnology stocks by fair value, valuation, financial quality, profitability, risk, and market outlook.

Emergent Biosolutions Inc (EBS)
Fair Value1.1% Upside Fair Analyst88.0% Upside Market Cap300.8 M P/E— Yield0.0% HealthFair
  NYSE
Lineage Cell Therapeutics Inc (LCTX)
Fair Value15.2% Upside Fair Analyst459.5% Upside Market Cap248.6 M P/E— Yield0.0% HealthFair
  NYSE
AbbVie Inc (ABBV)
Fair Value-2.2% Downside Fair Analyst6.3% Upside Market Cap509.5 B P/E49.5x Yield2.3% HealthGood
  NYSE
Actinium Pharmaceuticals Inc (ATNM)
Fair Value34.7% Upside Undervalued Analyst207.7% Upside Market Cap40.874 M P/E3.6x Yield0.0% HealthGreat
  NYSE
Armata Pharmaceuticals Inc (ARMP)
Fair Value-17.4% Downside Fair Analyst483.3% Upside Market Cap111.5 M P/E— Yield0.0% HealthWeak
  NYSE
CEL-SCI Corp (CVM)
Fair Value58.4% Upside Bargain Analyst812.4% Upside Market Cap24.097 M P/E— Yield0.0% HealthWeak
  NYSE
Perspective Therapeutics Inc (CATX)
Fair Value45.3% Upside Undervalued Market Cap89.997 M P/E— Yield0.0% HealthWeak
  NYSE
Protalix Biotherapeutics Inc (PLX)
Fair Value-2.3% Downside Fair Analyst338.2% Upside Market Cap202.2 M P/E10.7x Yield0.0% HealthGreat
  NYSE
Theriva Biologics Inc (TOVX)
Fair Value54.5% Upside Bargain Market Cap7.728 M P/E— Yield0.0% HealthWeak
  NYSE
Arcus Biosciences Inc (RCUS)
Fair Value-27.5% Downside Overvalued Analyst131.8% Upside Market Cap2.547 B P/E— Yield0.0% HealthWeak
  NYSE
Biohaven Pharmaceutical Holding Co Ltd (BHVN)
Fair Value21.6% Upside Undervalued Analyst70.7% Upside Market Cap2.1 B P/E— Yield0.0% HealthWeak
  NYSE
Can Fite Biopharma Ltd ADR (CANF)
Fair Value55.5% Upside Bargain Analyst400.0% Upside Market Cap5.129 M P/E— Yield0.0% HealthWeak
  NYSE
Matinas BioPharma Holdings Inc (MTNB)
Fair Value51.8% Upside Bargain Market Cap1.136 M P/E— Yield0.0% HealthFair
  NYSE
NanoViricides Inc (NNVC)
Fair Value-24.7% Downside Overvalued Analyst365.1% Upside Market Cap32.927 M P/E— Yield0.0% HealthFair
  NYSE
Oragenics Inc (OGEN)
Fair Value54.4% Upside Bargain Market Cap1.575 M P/E— Yield0.0% HealthWeak
  NYSE
Adc Therapeutics SA (ADCT)
Fair Value6.7% Upside Fair Analyst103.3% Upside Market Cap209.4 M P/E— Yield0.0% HealthFair
  NYSE
Aeon Biopharma Inc (AEON)
Fair Value86.1% Upside Bargain Market Cap7.886 M P/E— Yield0.0% HealthWeak
  NYSE
Annovis Bio Inc (ANVS)
Fair Value88.1% Upside Bargain Market Cap28.499 M P/E— Yield0.0% HealthWeak
  NYSE
Biomx Inc (PHGE)
  NYSE
Serina Therapeutics Inc (SER)
Fair Value34.3% Upside Undervalued Analyst475.8% Upside Market Cap41.911 M P/E— Yield0.0% HealthWeak
  NYSE
AIM ImmunoTech Inc (AIM)
Fair Value34.2% Upside Undervalued Market Cap4.63 M P/E— Yield0.0% HealthWeak
  NYSE
Apimeds Pharma US Ltd (APUS)
Market Cap4.12 M P/E— Yield0.0% HealthWeak
  NYSE
Azitra Inc (AZTR)
Fair Value40.6% Upside Undervalued Analyst796.4% Upside Market Cap4.394 M P/E— Yield0.0% HealthWeak
  NYSE
Calidi Biotherapeutics Inc (CLDI)
Fair Value36.2% Upside Undervalued Market Cap2.509 M P/E— Yield0.0% HealthWeak
  NYSE
Evommune Inc (EVMN)
Fair Value24.8% Upside Undervalued Analyst250.6% Upside Market Cap231.2 M P/E— Yield0.0% HealthFair
  NYSE
Kairos Pharma Ltd (KAPA)
Fair Value51.2% Upside Bargain Market Cap1.539 M P/E— Yield0.0% HealthWeak
  NYSE
Maia Biotechnology Inc (MAIA)
Fair Value26.6% Upside Undervalued Market Cap63.259 M P/E— Yield0.0% HealthWeak
  NYSE
OS Therapies Inc (OSTX)
Fair Value51.1% Upside Bargain Analyst767.3% Upside Market Cap45.286 M P/E— Yield0.0% HealthWeak
  NYSE
Pelthos Therapeutics Inc (PTHS)
Fair Value41.4% Upside Undervalued Analyst433.0% Upside Market Cap35.605 M P/E— Yield0.0% HealthWeak
  NYSE
Regentis Biomaterials Ltd (RGNT)
Fair Value14.4% Upside Fair Analyst754.7% Upside Market Cap8.218 M P/E— Yield0.0% HealthWeak
  NYSE
Explore listed stocks on NYSE with company information and fair value data.